Axonics® to Participate in Piper Sandler Virtual Healthcare Conference
08 November 2021 - 10:00PM
Business Wire
Axonics, Inc. (Nasdaq: AXNX), a global medical technology
company that is developing and commercializing novel products for
the treatment of bladder and bowel dysfunction, is scheduled to
participate in the Piper Sandler Virtual Healthcare Conference on
December 1, 2021.
In advance of the virtual conference, a pre-recorded fireside
chat with Axonics senior management will be made available on
Monday, November 22 at 10:00 AM Eastern Time. Interested parties
may access the fireside chat by visiting the Axonics investor
relations website.
About Axonics
Based in Irvine, Calif., Axonics is a global medical technology
company that is developing and commercializing novel products for
adults with bladder and bowel dysfunction. The company’s
rechargeable sacral neuromodulation (SNM) system provides patients
suffering from overactive bladder and/or fecal incontinence with
long-lived, easy to use, safe, clinically effective therapy. In
addition, Axonics’ best-in-class urethral bulking agent, Bulkamid®,
provides safe and durable symptom relief to women with stress
urinary incontinence (SUI).
Overactive bladder affects an estimated 87 million adults in the
U.S. and Europe, with an additional 40 million adults estimated to
suffer from fecal incontinence. SUI affects an estimated 20 million
women in the U.S. alone. Axonics’ clinically proven products are
offered at hundreds of medical centers across the U.S. and abroad.
Reimbursement coverage is well established in the U.S. and is a
covered service in most European countries. For more information,
visit www.axonics.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211108005068/en/
Neil Bhalodkar Investor Relations 949-336-5293
ir@axonics.com
Axonics (NASDAQ:AXNX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Axonics (NASDAQ:AXNX)
Historical Stock Chart
From Apr 2023 to Apr 2024